prednisolone has been researched along with Cancer of ILEUM in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
"The risk of colorectal cancer was not increased, either in the total group of patients or in patients with colonic Crohn's disease exclusively (standardized morbidity ratio, 1." | 1.32 | Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. ( Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fossati, M | 1 |
Buzzonetti, A | 1 |
Monego, G | 1 |
Catzola, V | 1 |
Scambia, G | 1 |
Fattorossi, A | 1 |
Battaglia, A | 1 |
Tokura, T | 1 |
Nishikawa, S | 1 |
Yachi, T | 1 |
Umehara, M | 1 |
Umehara, Y | 1 |
Murata, A | 1 |
Takahashi, K | 1 |
Morita, T | 1 |
Campbell, W | 1 |
Baird, E | 1 |
Murtagh, K | 1 |
Eedy, D | 1 |
Hannon, R | 1 |
Pranesh, N | 1 |
Motegi, S | 1 |
Nishizaki, Y | 1 |
Muramatsu, C | 1 |
Nakamura, H | 1 |
Kobayashi, F | 1 |
Shiozawa, H | 1 |
Kamochi, J | 1 |
Itakura, M | 1 |
Shibuya, M | 1 |
Ogawa, T | 1 |
Matsuzaki, S | 1 |
Jess, T | 1 |
Winther, KV | 1 |
Munkholm, P | 1 |
Langholz, E | 1 |
Binder, V | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Two-arm, Randomized, Open-label, Phase IIIb Study Investigating the Safety of a 3 Hour i.p. Infusion of Catumaxomab With and Without Prednisolone Premedication in Patients With Malignant Ascites Due to Epithelial Cancer[NCT00822809] | Phase 3 | 230 participants (Actual) | Interventional | 2008-12-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for prednisolone and Cancer of ILEUM
Article | Year |
---|---|
Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).
Topics: Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Line, Tumor; F | 2015 |
5 other studies available for prednisolone and Cancer of ILEUM
Article | Year |
---|---|
[A Case of Extranodal Nasal Type, NK/T Cell Lymphoma in the Ileum with Perforated Peritonitis during Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; | 2015 |
Post-operative pyoderma gangrenosum in association with ileal carcinoid tumour.
Topics: Aged; Anti-Inflammatory Agents; Carcinoid Tumor; Colectomy; Humans; Ileal Neoplasms; Laparoscopy; Ma | 2010 |
Lymphoma in an ileostomy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colitis, Ulcerative; Combined Modal | 2002 |
Hemophagocytic syndrome in ileum-origin B-cell lymphoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2003 |
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hor | 2004 |